Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,488 | -52,697 | -39,156 | -21,413 | -6,134 |
| Depreciation Amortization | 487 | 2,003 | 1,346 | 884 | 450 |
| Accounts receivable | -114 | 212 | -3,480 | 41 | -1,246 |
| Accounts payable and accrued liabilities | -2,082 | 1,642 | -1,849 | -1,111 | 2,696 |
| Other Working Capital | 741 | 5,000 | -443 | 946 | 287 |
| Other Operating Activity | -2,213 | -4,271 | 3,442 | -2,838 | -1,012 |
| Operating Cash Flow | $-20,669 | $-48,111 | $-40,140 | $-23,491 | $-4,959 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -39 | -421 | -371 | -159 | -30 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -168 | -164 |
| Other Investing Activity | 0 | 0 | 0 | -168 | -164 |
| Investing Cash Flow | $-39 | $-421 | $-371 | $-327 | $-194 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 55,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 50,599 | 3 | 3 | 3 |
| Other Financing Activity | 897 | -48 | 0 | 0 | 0 |
| Financing Cash Flow | $55,897 | $50,551 | $3 | $3 | $3 |
| Exchange Rate Effect | 588 | 556 | -2,064 | -3,617 | -3,749 |
| Beginning Cash Position | 66,417 | 63,842 | 63,842 | 63,842 | 63,842 |
| End Cash Position | 102,194 | 66,417 | 21,270 | 36,410 | 54,943 |
| Net Cash Flow | $35,777 | $2,575 | $-42,572 | $-27,432 | $-8,899 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,669 | -48,111 | -40,140 | -23,491 | -4,959 |
| Capital Expenditure | -39 | -421 | -371 | -159 | -30 |
| Free Cash Flow | -20,708 | -48,532 | -40,511 | -23,650 | -4,989 |